The DOI matches its Crossref record, with a small difference in title or year; 54 of the 56 references it cites were found in a registry or an index.
Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Open accessAbstract
CONTEXT: Antidepressant medications represent the best established treatment for major depressive disorder, but there is little evidence that they have a specific pharmacological effect relative to pill placebo for patients with less severe depression. OBJECTIVE: To estimate the relative benefit of medication vs placebo across a wide range of initial symptom severity in patients diagnosed with depression. DATA SOURCES: PubMed, PsycINFO, and the Cochrane Library databases were searched from January 1980 through March 2009, along with references from meta-analyses and reviews. STUDY SELECTION: Randomized placebo-controlled trials of antidepressants approved by the Food and Drug Administration in the treatment of major or minor depressive disorder were selected. Studies were included if their authors provided the requisite original data, they comprised adult outpatients, they included a medication vs placebo comparison for at least 6 weeks, they did not exclude patients on the basis of a placebo washout period, and they used the Hamilton Depression Rating Scale (HDRS). Data from 6 studies (718 patients) were included. DATA EXTRACTION: Individual patient-level data were obtained from study authors. RESULTS: Medication vs placebo differences varied substantially as a function of baseline severity. Among patients with HDRS scores below 23, Cohen d effect sizes for the difference between medication and placebo were estimated to be less than 0.20 (a standard definition of a small effect). Estimates of the magnitude of the superiority of medication over placebo increased with increases in baseline depression severity and crossed the threshold defined by the National Institute for Clinical Excellence for a clinically significant difference at a baseline HDRS score of 25. CONCLUSIONS: The magnitude of benefit of antidepressant medication compared with placebo increases with severity of depression symptoms and may be minimal or nonexistent, on average, in patients with mild or moderate symptoms. For patients with very severe depression, the benefit of medications over placebo is substantial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“antidepressants have been demonstrated efficient in treating MDD”
From SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli (2020) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fournier and colleagues meta-analysed trials of selective serotonin reuptake inhibitors and estimated the effect size.45 For mild to severe depression the effect estimates ranged from -0.17 to -0.11; this is lower than the effect size for smoking cessation.”
From Change in mental health after smoking cessation: systematic review and meta-analysis (2014) · cites this paper as [45]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For SSRIs, researchers have argued that a substantial portion of the perceived therapeutic benefit in double-blind randomized clinical trials (RCTs) may stem from placebo responses rather than the drug itself (Sugarman et al., 2014; Fournier et al., 2010; Kirsch, 2014; Moncrieff and Kirsch, 2015).”
From Revisiting the SSRI vs. placebo debate in the treatment of social anxiety disorder: the role of expectancy effects, neural responsivity, and monoamine transporters (2025) · cites this paper as Fournier et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The introduction and widespread use of selective serotonine uptake inhibitors (SSRI) [22, 23] and psychological therapy including cognitive behavioral therapy (CBT) [24, 25] meant that well tolerated and effective treatments for depression and anxiety disorders became available in primary care, widening the group of individuals eligible for treatment.”
From Trends in psychiatric diagnoses, medications and psychological therapies in a large Swedish region: A population-based study (2020) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“there are differences in individual response”
From SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli (2020) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, the effect sizes are generally higher than those obtained for pharmacological treatment of mild-to-moderate depression [34]”
From One-Day Acceptance and Commitment Therapy Compared to Support for Depressed Migraine Patients: a Randomized Clinical Trial. (2020) · cites this paper as [34]
In the citing paper
“Two individual participant data meta-analysis (26, 27) indicated that patients with lower baseline severity would achieve smaller improvement compared to placebo.”
In the citing paper
“Individual-level meta-analyses have found a direct relationship between the magnitude of depressive symptoms and the effectiveness of antidepressants.8–10”
In the citing paper
“Thus, the benefits of antidepressants in non-severe depression have been argued to be minimal.8 11”
In the citing paper
“One small individual patient data meta-analysis found support for increasing benefit with increasing severity of depression,20 but three larger individual patient data meta-analyses did not find any such effect of antidepressants compared with placebo on depression severity .44–46”
From Should antidepressants be used for major depressive disorder? (2020) · cites this paper as [20]
In the citing paper
“For example, meta-analysis has demonstrated that antidepressants, though widely prescribed as a treatment for MDD, may be no more effective than placebo for mild to moderate levels of symptom severity; clinically significant benefits are only observed at “very severe” levels of impairment (18).”
From Depression in diabetes: have we been missing something important? (2011) · cites this paper as [18]
In the citing paper
“For example, meta-analysis has demonstrated that antidepressants, though widely prescribed as a treatment for MDD, may be no more effective than placebo for mild to moderate levels of symptom severity; clinically significant benefits are only observed at “very severe” levels of impairment (18).”
From Depression in diabetes: have we been missing something important? (2011) · cites this paper as [18]
In the citing paper
“Although antidepressants are unlikely to be effective in most presentations of distress (18), physical activity, psychotherapeutic approaches, and discussions with diabetes team members can be effective.”
From Depression in diabetes: have we been missing something important? (2011) · cites this paper as [18]
In the citing paper
“The strength of the pooled standardised mean difference in change was clinically important - the association between smoking cessation and change in depression and anxiety was equal to or larger than the estimate from trials of antidepressants versus placebo.”
From An application of the stress-diathesis model: A review about the association between smoking tobacco, smoking cessation, and mental health (2023) · cites this paper as Fournier et al., 2010
In the citing paper
“A meta-analysis of individual-level data from randomised controlled trials (RCTs) of antidepressants for”
From An application of the stress-diathesis model: A review about the association between smoking tobacco, smoking cessation, and mental health (2023) · cites this paper as Fournier et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,603
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
Statistical Power Analysis for the Behavioral Sciences (2nd ed.).
Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,421
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
Elkin, I. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110013002 · Cited by 2,300
Dimidjian, S., Hollon, S. D., Dobson, K. S., Schmaling, K. B., Kohlenberg, R. J., Addis, M. E., Gallop, R., McGlinchey, J. B., Markley, D. K., Gollan, J. K., et al. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.4.658 · Cited by 1,607
Self-citationOstwald, P. F. (1960) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1960.14.4.817 · Cited by 1,422
The Hamilton Depression Rating Scale: Has the Gold Standard Become a Lead Weight?
Bagby, R. M., Ryder, A. G., Schuller, D. R., & Marshall, M. B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.12.2163 · Cited by 1,148
Research works printed but not linked: 1
- [3]Depression Guideline Panel Depression in primary care: Vol. 2. Treatment of major depression Clinical Practice Guideline No. 5. AHCPR Publication No. 93-0551 Rockville, MD U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research 1993
Cited by
Sorted by citations
Items 601–700 of 1,006
Can attention control conditions have detrimental effects on behavioral medicine randomized trials?
Pagoto, S. L., McDermott, M. M., Reed, G., Greenland, P., Mazor, K. M., Ockene, J. K., Whited, M., Schneider, K., Appelhans, B., Leung, K., et al. (2013) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3182765dd2 · Cited by 35
Cox, N., & Webb, L. (2015) · Sociology of Health & Illness · doi:10.1111/1467-9566.12230 · Cited by 45
Wang, Y., Wang, C., Zhou, J., Chen, X., Liu, R., Zhang, Z., Feng, Y., Feng, L., Liu, J., Zhou, Y., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03117-1 · Cited by 35
Cognitive and behavior therapy in the treatment and prevention of depression
Hollon Steven, D. (2011) · Depression and Anxiety · doi:10.1002/da.20797 · Cited by 37
Kane, J. C., Murray, L. K., Cohen, J. A., Dorsey, S., Skavenski, S. V. W., Henderson, J. G., Imasiku, M. L., Mayeya, J., & Bolton, P. A. (2016) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12623 · Cited by 36
Type 2 diabetes and influence of diabetes-specific distress on depression
Roy, M., Sengupta, N., Sahana, P. K., Das, C., Talukdar, P. S., Baidya, A., & Goswami, S. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.07.006 · Cited by 35
Treating major depression and comorbid disorders with transcranial magnetic stimulation
Thompson, L. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.07.025 · Cited by 34
Qiao, Y., Zhou, J., Liang, J., Deng, X., Zhang, Z., Huang, H., Li, S., Dai, S.-F., Liu, C., Luan, Z., et al. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153436 · Cited by 34
Wang, X., Feng, S., Wang, Y., Zhang, N., Wang, Z., & Zhang, Y. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114960 · Cited by 34
A review of the neurobiological effects of psychotherapy for depression.
Sharpley, C. F. (2010) · Psychotherapy · doi:10.1037/a0021177 · Cited by 36
Pregnancy Outcome Following Maternal Exposure to Mirtazapine: A Multicenter, Prospective Study
Winterfeld, U., Klinger, G., Panchaud, A., Stephens, S., Arnon, J., Malm, H., te Winkel, B., Clementi, M., Pistelli, A., Maňáková, E., et al. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000309 · Cited by 34
Is Depression the Wrong Treatment Target for Improving Outcome in Coronary Artery Disease?
Rafanelli, C., Sirri, L., Grandi, S., & Fava, G. A. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000351586 · Cited by 36
Walter, K. H., Otis, N. P., Ray, T. N., Glassman, L. H., Beltran, J. L., Kobayashi Elliott, K. T., & Michalewicz-Kragh, B. (2023) · BMC Psychiatry · doi:10.1186/s12888-022-04452-7 · Cited by 33
Webb, C. A., Olson, E. A., Killgore, W. D. S., Pizzagalli, D. A., Rauch, S. L., & Rosso, I. M. (2018) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2017.08.005 · Cited by 34
The placebo effect and homeopathy
Teixeira, M. Z., Guedes, C. H. F. F., Barreto, P. V., & Martins, M. A. (2010) · Homeopathy · doi:10.1016/j.homp.2010.02.001 · Cited by 37
Homeopathic medical practice for anxiety and depression in primary care: the EPI3 cohort study
for the EPI3-LA-SER group, Grimaldi‐Bensouda, L., Abenhaim, L., Massol, J., Guillemot, D., Avouac, B. P., Duru, G., Lert, F., Magnier, A., Rossignol, M., et al. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1104-2 · Cited by 33
Aprahamian, I., Suemoto, C. K., Lin, S. M., de Siqueira, A. S. S., Biella, M. M., de Melo, B. A. R., & Filho, W. J. (2018) · International Psychogeriatrics · doi:10.1017/s104161021800100x · Cited by 33
Recent Developments in the Treatment of Depression
Hollon, S. D., Cohen, Z. D., Singla, D. R., & Andrews, P. W. (2019) · Behavior Therapy · doi:10.1016/j.beth.2019.01.002 · Cited by 37
Self-citationHall, M., Dobson, F., Ginckel, A. V., Nelligan, R. K., Collins, N. J., Smith, M. D., Ross, M. H., Smits, E. J., & Bennell, K. L. (2021) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2021.07.007 · Cited by 33
Horowitz, M., & Wilcock, M. (2022) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2020.000080 · Cited by 33
Effects of virtual reality-based intervention on depression in stroke patients: a meta-analysis
Liu, H., Cheng, Z., Wang, S., Jia, Y., & Li, C. (2023) · Scientific Reports · doi:10.1038/s41598-023-31477-z · Cited by 37
Hsieh, M.-Y., Ponsford, J. L., Wong, D. K., Schönberger, M., McKay, A., & Haines, K. (2012) · Brain Injury · doi:10.3109/02699052.2011.635365 · Cited by 33
Wang, S., Chen, Y., Zhao, S., Xu, X., Liu, X., Liu, B., & Zhang, G. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.02.031 · Cited by 33
Depression in the Primary Care Setting
Ellis, P., Kitay, B. M., & Schmidt, C. J. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1903259 · Cited by 35
Schuit, E., Li, A. H., & Ioannidis, J. P. A. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyy239 · Cited by 27
Thorpe, J. M., Thorpe, C. T., Kennelty, K. A., & Chewning, B. A. (2012) · Medical Care · doi:10.1097/mlr.0b013e31821a933f · Cited by 32
Psychiatric consultation in the collaborative care model: The “bipolar sieve” effect
Phelps, J. R., & James, J. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.06.017 · Cited by 34
Kudlow, P. A., Cha, D. S., & Mclntyre, R. S. (2012) · The Canadian Journal of Psychiatry · doi:10.1177/070674371205701211 · Cited by 32
Bet, P. M., Hugtenburg, J. G., Penninx, B. W. J. H., van Balkom, A. J. L. M., Nolen, W. A., & Hoogendijk, W. J. G. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.06.023 · Cited by 33
Fabre, L. F., Brown, C., Smith, L. C., & Derogatis, L. R. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02216.x · Cited by 33
Vaidyanathan, U., Vrieze, S. I., & Iacono, W. G. (2015) · Psychological Inquiry · doi:10.1080/1047840x.2015.1015367 · Cited by 36
Kelly, J., Rubenfeld, G. D., Masson, N., Min, A., & Adhikari, N. K. J. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002308 · Cited by 32
Roberts, H., Jacobs, R. H., Bessette, K. L., Crowell, S. E., Schreiner, M. W., Thomas, L. R., Easter, R. E., Pocius, S. L., Dillahunt, A. K., Frandsen, S. B., et al. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03193-3 · Cited by 41
Wang, X., Zhou, H., Wang, X., Lei, K., & Wang, X. (2021) · Molecules · doi:10.3390/molecules26185556 · Cited by 32
Babb, J. A., Deligiannidis, K. M., Murgatroyd, C., & Nephew, B. C. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.03.039 · Cited by 32
Rajeswaran, T., Plymen, C. M., & Doherty, A. M. (2017) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2017.1401085 · Cited by 32
The conundrum of depression clinical trials: one size does not fit all
Khan, A., Mar, K. F., & Brown, W. A. (2018) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000229 · Cited by 30
Zazula, R., Husain, M. I., Mohebbi, M., Walker, A. J., Chaudhry, I. B., Khoso, A. B., Ashton, M. M., Agustini, B., Husain, N., Deakin, J., et al. (2021) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867420965697 · Cited by 31
Fountoulakis, K. N., & Möller, H.-J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111421969 · Cited by 30
Kabra, A., Garg, R., Brimson, J. M., Živković, J., Almawash, S., Ayaz, M., Nawaz, A., Hassan, S. S. U., & BUNGAU, S. G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1046599 · Cited by 36
Sani, N. A., Yusoff, S. S. M., Norhayati, M. N., & Zainudin, A. M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20042828 · Cited by 31
Mavranezouli, I., Megnin‐Viggars, O., Pedder, H., Welton, N. J., Dias, S., Watkins, E. R., Nixon, N. L., Daly, C., Keeney, E., Eadon, H., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102780 · Cited by 38
Positioning mental health nursing practice within a positive health paradigm
Wand, T. (2012) · International Journal of Mental Health Nursing · doi:10.1111/j.1447-0349.2012.00848.x · Cited by 34
Park, Y.-M., Lee, B.-H., Um, T., & Kim, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091061 · Cited by 37
Wang, H. R., Woo, Y. S., Ahn, H. S., Ahn, I. M., Kim, H. J., & Bahk, W. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv023 · Cited by 34
Drewniany, E., Han, J., Hancock, C., Jones, R. L., Lim, J., Gorgani, N. N., Sperry, J., Yu, H. J., & Raffa, R. B. (2014) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12238 · Cited by 32
Causal Effects In Psychotherapy: Counterfactuals Counteract Overgeneralization
Höfler, M., Gloster, A. T., & Hoyer, J. (2010) · Psychotherapy Research · doi:10.1080/10503307.2010.501041 · Cited by 30
Tadić, A., Wagner, S., Gorbulev, S., Dahmen, N., Hiemke, C., Braus, D. F., & Lieb, K. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-16 · Cited by 33
Shin, N. E., Hill‐Briggs, F., Langan, S. J., Payne, J. L., Lyketsos, C. G., & Golden, S. H. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.026 · Cited by 31
Gu, Z., Wang, W.-T., Qian, H., Zhou, A., Sun, H., Zhang, Q., & Li, J. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126703 · Cited by 31
Lorenzo‐Luaces, L., Rodríguez‐Quintana, N., & Bailey, A. J. (2020) · Behaviour Research and Therapy · doi:10.1016/j.brat.2020.103637 · Cited by 30
Min, S., Kim, J., & Park, H. Y. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10427-7 · Cited by 35
Wang, J. T., Hoffman, B. M., & Blumenthal, J. A. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.513701 · Cited by 30
Trimmer, P. C., Higginson, A. D., Fawcett, T. W., McNamara, J. M., & Houston, A. I. (2015) · Evolution Medicine and Public Health · doi:10.1093/emph/eov009 · Cited by 33
Kovács, D., Gonda, X., Petschner, P., Édes, A. E., Eszlári, N., Bagdy, G., & Juhász, G. (2014) · Annals of General Psychiatry · doi:10.1186/1744-859x-13-17 · Cited by 31
(2016) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.140203 · Cited by 30
de Vries, Y. A., Roest, A. M., Burgerhof, J. G. M., & de Jonge, P. (2018) · Depression and Anxiety · doi:10.1002/da.22737 · Cited by 31
Baxter, L., & Fancourt, D. E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235334 · Cited by 30
Wolff, J., Reißner, P., Hefner, G., Normann, C., Kaier, K., Binder, H., Hiemke, C., Toto, S., Domschke, K., Marschollek, M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0255192 · Cited by 35
Effectiveness of medical interventions
Stegenga, J. (2015) · Studies in History and Philosophy of Science Part C Studies in History and Philosophy of Biological and Biomedical Sciences · doi:10.1016/j.shpsc.2015.06.005 · Cited by 30
The Borders of Mental Disorder in Psychiatry and the DSM
Pierre, J. M. (2010) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000390756.37754.68 · Cited by 31
Suggestion in the Treatment of Depression
Kirsch, I., & Low, C. B. (2013) · American Journal of Clinical Hypnosis · doi:10.1080/00029157.2012.738613 · Cited by 33
Sarris, J. J., Glick, R. M., Hoenders, R. H. J., Duffy, J., & Lake, J. (2013) · Advances in Integrative Medicine · doi:10.1016/j.aimed.2012.12.002 · Cited by 30
Hoirisch-Clapauch, S., Nardi, A. E., Gris, J., & Brenner, B. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.02.028 · Cited by 31
Psychiatric and Behavioral Aspects of Cardiovascular Disease
Vaccarino, V., & Bremner, J. D. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00091-3 · Cited by 30
Greene, M. E., Rolfson, O., Gordon, M., Annerbrink, K., Malchau, H., & Garellick, G. (2016) · Acta Orthopaedica · doi:10.1080/17453674.2016.1216181 · Cited by 30
Dunn, B. D., Widnall, E., Reed, N., Taylor, R. S., Owens, C. V., Spencer, A. E., Kraag, G., Kok, G., Geschwind, N., Wright, K. A., et al. (2019) · Pilot and Feasibility Studies · doi:10.1186/s40814-019-0438-1 · Cited by 35
Fann, J. R., Hong, F., Halpenny, B., Blonquist, T. M., & Berry, D. L. (2017) · Psycho-Oncology · doi:10.1002/pon.4250 · Cited by 28
The Role of Psychedelics and Counseling in Mental Health Treatment
Curtis, R., Roberts, L. C., Graves, E. G., Rainey, H. T., Wynn, D. D., Krantz, D., & Wieloch, V. (2020) · Journal of Mental Health Counseling · doi:10.17744/mehc.42.4.03 · Cited by 35
Parente, J., Gianlorenço, A. C., Rebello‐Sanchez, I., Kim, M., Prati, J. M., Kim, C. K., Choi, S., Song, J., & Fregni, F. (2023) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyad058 · Cited by 30
Evidenzbasierte Therapie der Depression: Die S3-Leitlinie unipolare Depression
Härter, M. C., Klesse, C., Bermejo, I., Bschor, T., Gensichen, J. S., Harfst, T., Hautzinger, M., Kolada, C., Kopp, I., Kühner, C., et al. (2010) · Der Nervenarzt · Cited by 29
Jimenez, D. E., Reynolds, C. F., Alegria, M. M., Harvey, P. D., & Bartels, S. J. (2015) · Trials · doi:10.1186/s13063-015-1113-3 · Cited by 30
Treatment of Postpartum Depression: Recommendations for the Clinician
O’Hara, M. W., & Engeldinger, J. (2018) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000353 · Cited by 34
Lopez-Maya, E., Olmstead, R., & Irwin, M. R. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219425 · Cited by 27
Buckman, J. E. J., Cohen, Z. D., O’Driscoll, C., Fried, E. I., Saunders, R., Ambler, G., DeRubeis, R. J., Gilbody, S. M., Hollon, S. D., Kendrick, T., et al. (2021) · Psychological Medicine · doi:10.1017/s0033291721001616 · Cited by 32
Self-citationYosaee, S., Keshtkaran, Z., Abdollahi, S., Shidfar, F., Sarris, J. J., & Soltani, S. (2021) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2021.04.006 · Cited by 30
Nettis, M. A. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100335 · Cited by 32
Transcranial ultrasound stimulation relieves depression in mice with chronic restraint stress
Zhu, Y., He, J., Wu, C., Wu, J., Cheng, Z., Chen, Y., Yuan, M., Zeng, L., & Ji, X. (2022) · Journal of Neural Engineering · doi:10.1088/1741-2552/ac8bfd · Cited by 29
Barbic, S. P., Durisko, Z., & Andrews, P. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112077 · Cited by 32
Castro-Rodríguez, J. I., Olariu, E., Garnier, C., Martín‐Lopez, L. M., Pérez, V., Alonso, J., & Forero, C. G. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.10.020 · Cited by 29
Psychiatric diagnoses are not mental processes: Wittgenstein on conceptual confusion
Rosenman, S. J., & Nasti, J. J. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412446090 · Cited by 29
Initial severity and efficacy of risperidone in autism: Results from the RUPP trial
Levine, S. Z., Kodesh, A., Goldberg, Y., Reichenberg, A., Furukawa, T. A., Kolevzon, A. L., & Leucht, S. (2016) · European Psychiatry · doi:10.1016/j.eurpsy.2015.11.004 · Cited by 29
Gobbi, G., Ghabrash, M. F., Núñez, N. A., Tabaka, J. M., Sante, J. D., Saint-Laurent, M., Vida, S., Kolivakis, T., Low, N. C. P., Cervantes, P., et al. (2017) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000196 · Cited by 29
Lupattelli, A., Twigg, M. J., Zagorodnikova, K., Moretti, M. E., Drozd, M., Panchaud, A., Rieutord, A., Juraški, R. G., Odalović, M., Kennedy, D. S., et al. (2018) · Clinical Epidemiology · doi:10.2147/clep.s156210 · Cited by 31
Noori, N., Bangash, M., Motaghinejad, M., Hosseini, P., & Noudoost, B. (2014) · Advanced Biomedical Research · doi:10.4103/2277-9175.146377 · Cited by 27
Allida, S. M., Hsieh, C., Cox, K. L., Patel, K., Rouncefield‐Swales, A., Lightbody, C. E., House, A. O., & Hackett, M. L. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003437.pub5 · Cited by 29
Anatomy of a Woebot® (WB001): agent guided CBT for women with postpartum depression
Darcy, A. M., Beaudette, A., Chiauzzi, E. J., Daniels, J., Goodwin, K., Mariano, T. Y., Wicks, P. J., & Robinson, A. H. (2023) · Expert Review of Medical Devices · doi:10.1080/17434440.2023.2280686 · Cited by 32
Tonegawa‐Kuji, R., Hou, Y., Hu, B., Lorincz‐Comi, N. J., Pieper, A. A., Tousi, B., Leverenz, J. B., & Cheng, F. (2025) · PLoS Medicine · doi:10.1371/journal.pmed.1004568 · Cited by 30
Thombs, B. D., & Ziegelstein, R. C. (2013) · The Canadian Journal of Psychiatry · doi:10.1177/070674371305801207 · Cited by 27
Interpreting meta‐regression: application to recent controversies in antidepressants’ efficacy
Petkova, E., Tarpey, T., Huang, L., & Deng, L. (2013) · Statistics in Medicine · doi:10.1002/sim.5766 · Cited by 28
Gu, Z., Xiao, Y., Zhang, Q., & Li, J. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.11.007 · Cited by 28
Can knowledge of Placebo and Nocebo Mechanisms Help Improve Randomized Clinical Trials?
Carlino, E., & Vase, L. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.01.012 · Cited by 29
Konradt, C. E., Cardoso, T. D. A., Mondin, T. C., Souza, L. D. D. M., Kapczinski, F. P., da Silva, R. A., & Jansen, K. (2018) · Trends in Psychiatry and Psychotherapy · doi:10.1590/2237-6089-2017-0047 · Cited by 28
Guu, T., Mischoulon, D., Sarris, J. J., Hibbeln, J. R., McNamara, R. K., Hamazaki, K., Freeman, M. P., Maes, M. H. J., Matsuoka, Y., Belmaker, R. H., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.050 · Cited by 28
Review of the choice and use of antidepressant drugs
Bleakley, S. (2013) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.311 · Cited by 28
Mancini, M., Wade, A. G., Perugi, G., Lenox‐Smith, A., & Schacht, A. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.01.001 · Cited by 28
Are Antidepressants Effective in the Treatment of Postpartum Depression?
Sharma, V., & Sommerdyk, C. (2013) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.13r01529 · Cited by 28
Mojtabai, R. (2017) · Psychiatric Services · doi:10.1176/appi.ps.201600320 · Cited by 28
Abramowitz, J. S. (2017) · Behavior Therapy · doi:10.1016/j.beth.2017.06.002 · Cited by 28
y García, E. F., Duberstein, P. R., Paterniti, D. A., Cipri, C. S., Kravitz, R. L., & Epstein, R. M. (2012) · BMC Family Practice · doi:10.1186/1471-2296-13-64 · Cited by 31
Metadata
- Authors
- Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J.
- Affiliations
- University of Pennsylvania (US)
- University of New Mexico (US)
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2010-01-06
- Volume
- 303
- Issue
- 1
- Pages
- 47
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC3712503
- OpenAlex
- W2004762037
- Cited by
- 2,009
- References
- 56
- Citations by year
- 2026: 54 · 2025: 72 · 2024: 89 · 2023: 70 · 2022: 81 · 2021: 134 · 2020: 81 · 2019: 111 · 2018: 143 · 2017: 128 · 2016: 112 · 2015: 149 · 2014: 154 · 2013: 170 · 2012: 172
- FWCI
- 144.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Sanofi
- National Alliance for Research on Schizophrenia and Depression
- Universiteit Maastricht
- National Institute of Mental Health (K24MH001741, R10 MH50129, R01MH060998, K02MH001697, R10MH055875, R10MH055877)
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- antidepressants, major depressive disorder, depression severity, placebo response, Hamilton Depression Rating Scale, treatment effect heterogeneity, mild depression, antidepressant efficacy
- MeSH terms
- Adult, Antidepressive Agents, Depression, Major Depressive Disorder, Humans, Placebo Effect, Randomized Controlled Trials as Topic, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
